On Monday, Jan 22 UCSF #Bioethics will host a celebration of the career of Barbara Koenig, PhD. We hope people can join us for a great afternoon of conversation!
2:00-2:10pm - Welcome
Winston Chiong (UCSF)
2:10-2:50pm - Panel: Race &
Genomics
Sandra Soo-Jin Lee (Columbia)
Jennifer James (UCSF)
Janet Shim (UCSF)
Moderator: Daphne Martschenko (Stanford)
2:50-3:30pm - Panel: Culture & End of Life Care
Bill Andereck (Sutter Health)
LaVera Crawley (CommonSpirit)
Bridget Sumser (UCSF)
Moderator: Ruchika Mishra (Sutter Health)
3:50-4:25pm - Panel: Moving Beyond Consent to Achieve Governance in Biomedicine
Julie Harris-Wai (UCSF)
David Magnus (Stanford)
Julia Brown (UCSF)
Moderator: Mildred Cho (Stanford)
4:25-5:00pm - Fireside Chat: The Future of Bioethics Scholarship
Sandra Soo-Jin Lee & Barbara Koenig
We're #hiring! My lab is looking for an assistant clinical research coordinator for #neuroethics research on novel neurotechnology. We're particularly interested in candidates with prior coursework or experience in #neuroscience, #bioethics, and/or #qualitative methods. Please share with anyone who might be interested: https://sjobs.brassring.com/TGnewUI/Search/home/HomeWithPreLoad?partnerid=6495&siteid=5861&PageType=JobDetails&jobid=3505283#jobDetails=3505283_5861 #UCSF #ScienceJobs #neurotech #jobs
Troubling and plausible allegations of image/data manipulation in #Alzheimer's disease and #stroke research, including about a compound to be evaluated in an upcoming NIH-funded trial of 1400 people with acute strokes: “As a site investigator for stroke trials, I would not agree to participate in the phase 3 trial based on what I know now.”
With Clara Sanches at #sfn23 , a #driftdiffusion model analysis of cognitive slowing in aging
For those at #sfn23 next week, I will be there with my postdoc Clara Sanches, who will be presenting at:
Wednesday 3-4pm PSTR570.16 / VV40
Age related processes impacting processing speed: a diffusion model analysis
We consider effects of age (considered as a continuous variable, rather than comparing separate age cohorts) on drift rate in 3 separate tasks (delay discounting, emotion recognition, and verbal memory), potentially mediated by white matter integrity.
Interesting new piece reflecting the differing reception of new #Alzheimer's treatments among different subspecialties: Monoclonal Anti-amyloid Antibodies for the Treatment of Alzheimer's Disease and the Hesitant Geriatrician
“The hesitant #geriatrician may question the magnitude of these drugs benefits and whether these benefits are worth their risks, but a well-informed patient may see these same data and want to pursue treatment. It is not despite but because of patients like these that we geriatricians need to be involved in every step of the appropriate use of these drugs.”
https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18652?af=R